Skip to main content
Log in

The effects of calcium-regulating-hormone on BMC in patients with CRF

  • Published:
Journal of Tongji Medical University Aims and scope Submit manuscript

Summary

By means of single photon absorptiometry, bone material content (BMC) on centerbrachium was detected in 34 patients with chronic renal failure (CRF) and 34 sex-age-matched normal controls, and their serum parathyroid hormone (PTH), calcitonin (CT) were also measured by radioimmunoassay. It was found that (1) the mean BMC was obviously lower in patients with CRF than that in the normal controls; (2) PTH and CT obviously rose in patients with CRF; (3) the decrease of BMC was strongly correlated with that of creatinine clearance (Ccr). Furthermore, the more Ccr decreases, the more PTH in blood increases; no relations have been found between BMC and the serum levels of CT. The authors suggest that the development of osteoporosis with CRF is due to the secondary increase of PTH in blood but the effect of increased serum CT levels was not so obvious. Therefore, lowering blood PTH concentrations by parathyroidectomy or renal transplantation may be beneficial to curing osteoporosis of patients with CRF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. 1987; 773–783

  2. 1990; 6 (5): 317

  3. Cameron J R, Sorenson J, Measurement of bone mineral in vivo: an improved method. Science, 1963; 142: 230

    Article  PubMed  CAS  Google Scholar 

  4. Riggs B L, Melton L J, Medical progress series: Involution Osteoporosis. N Eng Med, 1986; 314: 1676

    CAS  Google Scholar 

  5. McCarthy J T, Kle G G, Kao P C, Serum bioactive parathyroid hormone in hemodialysis patients. J clin End crubot Metab, 1989; 69 (2): 340

    Article  Google Scholar 

  6. Keye M, D’Amour P, Henderson. Elective total parathyroidertomy without autotransplant in end-stage renal disease. Kidney int, 1989; 35 (6): 1390

    Article  Google Scholar 

  7. D’Angel A, Bcnucci E, Gianninz S, Evogenous calcibonin protects against renal bone disease in rats with early renal failure. Bone miner, 1987; 3 (2): 171

    Google Scholar 

  8. Mulder H, Sicberbusch I, Hackeng W H L, Enhanced Calcitonin Release in chronic renal failure depending on the absence of severe secondary hyperparathyroidism. Nephron 1982; 31: 123

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yong-man, L., Hui-wen, X. & Kuo-huan, L. The effects of calcium-regulating-hormone on BMC in patients with CRF. Journal of Tongji Medical University 15, 95–97 (1995). https://doi.org/10.1007/BF02887910

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02887910

Key words

Navigation